immunotherapy

You have access
Response to combined peptide receptor radionuclide therapy and checkpoint immunotherapy with ipilimumab plus nivolumab in metastatic Merkel cell carcinoma
Justin Ferdinandus, Wolfgang Peter Fendler, Katharina Lueckerath, Christoph Berliner, Sabine Kurzidem, Eva Hadaschik, Joachim Klode, Lisa Zimmer, Elisabeth Livingstone, Dirk Schadendorf, Ken Herrmann, Juergen Christian Becker and Selma Ugurel

Journal of Nuclear Medicine September 2, 2021, jnumed.121.262344; DOI: https://doi.org/10.2967/jnumed.121.262344
You have access
CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of ⁸⁹Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody
Michael D. Farwell, Raymond F. Gamache, Hasan Babazada, Matthew D. Hellmann, James J. Harding, Ron Korn, Alessandro Mascioni, William Le, Ian Wilson, Michael S. Gordon, Anna M. Wu, Gary A. Ulaner, Jedd D. Wolchok, Michael A. Postow and Neeta A. Pandit-Taskar

Journal of Nuclear Medicine August 19, 2021, jnumed.121.262485; DOI: https://doi.org/10.2967/jnumed.121.262485
You have access
PD-L1 PET/CT imaging with radiolabeled durvalumab in patients with advanced stage non-small cell lung cancer.
Jasper Smit, Frank Johannes Borm, Anna-Larissa N Niemeijer, Marc C Huisman, Otto S Hoekstra, Ronald Boellaard, Daniela Elena Oprea-Lager, Danielle J Vugts, Guus AMS van Dongen, Berlinda J de Wit- van der Veen, Erik Thunnissen, Egbert F Smit and Adrianus J de Langen

Journal of Nuclear Medicine August 12, 2021, jnumed.121.262473; DOI: https://doi.org/10.2967/jnumed.121.262473
You have access
First-in-human study of ⁸⁹Zr-pembrolizumab PET/CT in patients with advanced stage non-small-cell lung cancer
Anna-Larissa Nadia Niemeijer, Daniela E Oprea Lager, Marc C Huisman, Otto S Hoekstra, Ronald Boellaard, Berlinda van de Veen, Idris Bahce, Danielle J Vugts, Guus AMS van Dongen, Erik Thunnissen, Egbert Smit and Adrianus J. de Langen

Journal of Nuclear Medicine July 22, 2021, jnumed.121.261926; DOI: https://doi.org/10.2967/jnumed.121.261926
You have access
Prognostic value of bone marrow metabolism on pretreatment ¹⁸F-FDG PET/CT in patients with metastatic melanoma treated with anti-PD-1 therapy
Ryusuke Nakamoto, Lisa C. Zaba, Tie Liang, Sunil Arani Reddy, Guido Davidzon, Carina Mari Aparici, Judy Nguyen, Farshad Moradi, Andrei Iagaru and Benjamin Lewis Franc

Journal of Nuclear Medicine February 5, 2021, jnumed.120.254482; DOI: https://doi.org/10.2967/jnumed.120.254482
You have access
Immune-Checkpoint Blockade Enhances ²²⁵Ac-PSMA617 Efficacy in a Mouse Model of Prostate Cancer
Johannes Czernin, Kyle Current, Christine E. Mona, Lea Nyiranshuti, Firas Hikmat, Caius G. Radu and Katharina Lückerath

Journal of Nuclear Medicine February 1, 2021, 62 (2) 228-231; DOI: https://doi.org/10.2967/jnumed.120.246041
You have access
Development and Evaluation of Interleukin-2–Derived Radiotracers for PET Imaging of T Cells in Mice
Elly L. van der Veen, Frans V. Suurs, Frederik Cleeren, Guy Bormans, Philip H. Elsinga, Geke A.P. Hospers, Marjolijn N. Lub-de Hooge, Elisabeth G.E. de Vries, Erik F.J. de Vries and Inês F. Antunes

Journal of Nuclear Medicine September 1, 2020, 61 (9) 1355-1360; DOI: https://doi.org/10.2967/jnumed.119.238782
You have access
Imaging the Cancer Immune Environment and Its Response to Pharmacologic Intervention, Part 1: The Role of ¹⁸F-FDG PET/CT
Amir Iravani and Rodney J. Hicks

Journal of Nuclear Medicine July 1, 2020, 61 (7) 943-950; DOI: https://doi.org/10.2967/jnumed.119.234278
You have access
Early ¹⁸F-FDG PET/CT Response Predicts Survival in Relapsed or Refractory Hodgkin Lymphoma Treated with Nivolumab
Aiping Chen, Fatima-Zohra Mokrane, Lawrence H. Schwartz, Franck Morschhauser, Apasia Stamatoullas, Jean-Marc Schiano de Colella, Laetitia Vercellino, Olivier Casasnovas, Adrien Chauchet, Alain Delmer, Emmanuelle Nicolas-Virelizier, Hervé Ghesquières, Marie-Pierre Moles-Moreau, Anna Schmitt, Rémy Dulery, Krimo Bouabdallah, Cecile Borel, Mohamed Touati, Benedicte Deau-Fischer, Frédéric Peyrade, Romain-David Seban, Guillaume Manson, Philippe Armand, Roch Houot and Laurent Dercle

Journal of Nuclear Medicine May 1, 2020, 61 (5) 649-654; DOI: https://doi.org/10.2967/jnumed.119.232827
Open Access
An ⁸⁹Zr-HDL PET Tracer Monitors Response to a CSF1R Inhibitor
Christian A. Mason, Susanne Kossatz, Lukas M. Carter, Giacomo Pirovano, Christian Brand, Navjot Guru, Carlos Pérez-Medina, Jason S. Lewis, Willem J.M. Mulder and Thomas Reiner

Journal of Nuclear Medicine March 1, 2020, 61 (3) 433-436; DOI: https://doi.org/10.2967/jnumed.119.230466

Main menu

User menu

Search

immunotherapy

Pages